D.A. Davidson & Co. Baxter International Inc Transaction History

D.A. Davidson & Co.

$12.1 Billion
Q4 2024

A detailed history of D.A. Davidson & Co. transactions in Baxter International Inc stock. As of the latest transaction made, D.A. Davidson & Co. holds 24,712 shares of BAX stock, worth $867,391. This represents 0.01% of its overall portfolio holdings.

Number of Shares

24,712

Previous 27,830 11.2%

Holding current value

$867,391

Previous $1.06 Million 31.82%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$28.63 - $37.84 $89,268 - $117,985	-3,118 Reduced 11.2%	24,712 $720,000
Q3 2024 Nov 13, 2024	SELL	$32.85 - $40.26 $40,734 - $49,922	-1,240 Reduced 4.27%	27,830 $1.06 Million
Q2 2024 Jul 31, 2024	SELL	$32.87 - $43.55 $16,237 - $21,513	-494 Reduced 1.67%	29,070 $972,000
Q1 2024 May 13, 2024	SELL	$37.88 - $43.77 $298,115 - $344,469	-7,870 Reduced 21.02%	29,564 $1.26 Million
Q4 2023 Feb 09, 2024	BUY	$31.71 - $38.95 $28,919 - $35,522	912 Added 2.5%	37,434 $1.45 Million
Q3 2023 Nov 08, 2023	SELL	$37.32 - $49.29 $90,127 - $119,035	-2,415 Reduced 6.2%	36,522 $1.38 Million
Q2 2023 Aug 10, 2023	SELL	$39.98 - $47.68 $957,720 - $1.14 Million	-23,955 Reduced 38.09%	38,937 $1.77 Million
Q1 2023 Apr 25, 2023	BUY	$37.58 - $52.57 $1.09 Million - $1.52 Million	28,887 Added 84.95%	62,892 $2.55 Million
Q4 2022 Feb 03, 2023	BUY	$49.7 - $57.71 $135,333 - $157,144	2,723 Added 8.7%	34,005 $1.73 Million
Q3 2022 Nov 07, 2022	SELL	$53.86 - $66.8 $23,752 - $29,458	-441 Reduced 1.39%	31,282 $1.69 Million
Q2 2022 Jul 28, 2022	BUY	$63.83 - $80.0 $7,787 - $9,760	122 Added 0.39%	31,723 $2.04 Million
Q1 2022 May 12, 2022	BUY	$76.85 - $89.45 $40,576 - $47,229	528 Added 1.7%	31,601 $2.45 Million
Q4 2021 Jan 31, 2022	SELL	$74.57 - $87.19 $1,491 - $1,743	-20 Reduced 0.06%	31,073 $2.67 Million
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $130,425 - $147,822	1,768 Added 6.03%	31,093 $2.5 Million
Q2 2021 Aug 10, 2021	BUY	$80.5 - $88.01 $27,772 - $30,363	345 Added 1.19%	29,325 $2.36 Million
Q1 2021 May 07, 2021	BUY	$76.38 - $86.03 $752,190 - $847,223	9,848 Added 51.47%	28,980 $2.44 Million
Q4 2020 Feb 10, 2021	BUY	$75.39 - $82.36 $30,985 - $33,849	411 Added 2.2%	19,132 $1.53 Million
Q3 2020 Nov 02, 2020	SELL	$78.33 - $90.73 $23,968 - $27,763	-306 Reduced 1.61%	18,721 $1.51 Million
Q2 2020 Aug 10, 2020	SELL	$78.66 - $94.14 $823,727 - $985,834	-10,472 Reduced 35.5%	19,027 $1.64 Million
Q1 2020 May 05, 2020	SELL	$71.57 - $93.3 $48,309 - $62,977	-675 Reduced 2.24%	29,499 $2.4 Million
Q4 2019 Feb 14, 2020	BUY	$76.7 - $88.45 $328,122 - $378,389	4,278 Added 16.52%	30,174 $2.52 Million
Q3 2019 Nov 05, 2019	BUY	$81.4 - $89.78 $38,746 - $42,735	476 Added 1.87%	25,896 $2.27 Million
Q2 2019 Aug 13, 2019	SELL	$73.44 - $82.41 $54,125 - $60,736	-737 Reduced 2.82%	25,420 $2.08 Million
Q1 2019 May 13, 2019	BUY	$64.48 - $81.31 $42,685 - $53,827	662 Added 2.6%	26,157 $2.02 Million
Q4 2018 Jan 29, 2019	SELL	$61.45 - $77.8 $178,082 - $225,464	-2,898 Reduced 10.21%	25,495 $1.68 Million
Q3 2018 Nov 13, 2018	SELL	$70.71 - $77.75 $136,399 - $149,979	-1,929 Reduced 6.36%	28,393 $2.19 Million
Q2 2018 Aug 02, 2018	BUY	$63.43 - $75.41 $43,766 - $52,032	690 Added 2.33%	30,322 $2.24 Million
Q1 2018 May 04, 2018	SELL	$62.56 - $72.26 $114,609 - $132,380	-1,832 Reduced 5.82%	29,632 $1.93 Million
Q4 2017 Feb 08, 2018	BUY	$61.45 - $66.05 $63,846 - $68,625	1,039 Added 3.41%	31,464 $2.03 Million
Q3 2017 Nov 08, 2017	BUY	$59.5 - $64.61 $21,896 - $23,776	368 Added 1.22%	30,425 $1.91 Million
Q2 2017 Aug 11, 2017	BUY	N/A	30,057	30,057 $0

Others Institutions Holding BAX

# of Institutions

939

Shares Held

468M

Call Options Held

2.57M

Put Options Held

3.29M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.7B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account